News Related News

Editas Medicine, Inc. Announces Pricing of $90 Million Offering of Common Stock

CAMBRIDGE, Mass., March 16, 2017 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced the pricing of an underwritten offering of 4,000,000 shares of its common stock at a price to the public of $22.50 [...]

By | March 20th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Evolva teams up with FCI to expand nootkatone and valencene sales & marketing in Europe

16 March 2017 – Evolva  announces that it is teaming up with Paris-based FCI to expand the European sales, marketing and distribution of its high-purity, sustainably sourced citrus ingredients, nootkatone and valencene. Nootkatone is a molecule that gives grapefruit its [...]

By | March 20th, 2017|Consumer Products & Manufacturing, Food, Fragrances, News|

Thermo Fisher Scientific Announces First-Ever Cloud-Based Application for Connectivity to Electronic Pipettes

WALTHAM, Mass.--(BUSINESS WIRE) Wednesday, March 15, 2017 8:30 am EDT --Life science researchers working across many applications can now benefit from the first-ever web-based pipetting application, developed to enable seamless connectivity with electronic pipettes for optimized performance and safe, efficient [...]

Synpromics Granted Key Patent in Synthetic Promoter Development

Edinburgh, UK, 16th March 2017 / Sciad Newswire / Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to announce it has been granted a key patent (EP2668277B1) by the European Patent Office, protecting PromPT™ - its proprietary synthetic [...]

By | March 16th, 2017|DNA Synthesis, Industry Providers, News, Press Releases|

Eurofins Genomics US Announces Commercial Launch of Next Generation DNA Synthesis Service

LOUISVILLE, Ky., March 14, 2017 /PRNewswire/ -- Eurofins Genomics, the pioneer of high-throughput oligonucleotide synthesis, announced the U.S. commercial launch of a unique DNA synthesis service based on the company's revolutionary next-generation synthesis platform. The service, which is designed to [...]

By | March 16th, 2017|DNA Synthesis, Industry Providers, News, Press Releases|

BioBright Tools Bring ‘Superpowers’ to the Biology Lab

March 14, 2017 09:00 AM Eastern Daylight Time  BOSTON--(BUSINESS WIRE)--BioBright, a firm developing technologies to enable more precise, more reproducible research protocols in biology, has improved the accuracy of a delicate laboratory technique by more than 20 times in the [...]